Skip to main content
On Demand

K-TRACS, Prescribing & You

Total Credits: 0.75 including 0.75 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
State Associations:
KAOM - Kansas
Gayle Donaldson, MBA
42 Minutes
Never expires.


K-TRACS, Prescribing & You, was first presented at the Kansas Association of Osteopathic Medicine Annual Conference 2023. This program now made available on-demand follows Gayle Donaldson, and her recommendation on best practices when prescribing K-TRACS.

Learning Objectives:

  1. Discuss recommendations and best practices for using K-TRACS
  2. Analyze the patient report to understand how to use patient information in clinical decision-making.
  3. Identify patient safety and care coordination recommendations.
  4. Explain K-TRACS Advisory Committee’s role and case review criteria.

Accreditation Statement:

KAOM is an accredited sponsor by the American Osteopathic Association for osteopathic continuing medical education for physicians. KAOM designates this program for a maximum of 1 AOA Category 1-A CME credits and will report CME and specialty credits commensurate with the physician’s participation. 

KAOM Grievance Policy:

KAOM strives to provide medical education programs that fulfill the needs of the attendees. Comments, questions, or complaints should be submitted in writing to Kemper Tell, Executive Director at P.O. Box 4368 Topeka, KS 66604 or

Faculty Disclosure Declaration:

Gayle Donaldson, had no affiliation or financial interest to disclose.



Gayle Donaldson, MBA's Profile

Gayle Donaldson, MBA Related Seminars and Products

Gayle Donaldson, MBA graduated with a BA in Communication Studies from Fort Hays State University and an MBA from Baker University. She has more than 10 years' experience in journalism, public relations, marketing, public information, graphic design and project management. She is currently the Public Information Officer at the Kansas Board of Pharmacy.She manages the K-TRACS website and social media prescence as well as creating public information healthcare professionals and consumers regarding the state's prescription drug monitoring program.